Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Summary of Segment Performance (Details)

v3.20.2
Segment Reporting - Summary of Segment Performance (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Segment Reporting Information [Line Items]        
Net revenue $ 914 $ 1,908 $ 3,188 $ 5,809
Cost of revenue 1,418 2,425 4,169 7,100
Gross profit (loss) (504) (517) (981) (1,291)
Vascular [Member]        
Segment Reporting Information [Line Items]        
Net revenue 68 226 259 1,121
Cost of revenue 515 920 1,593 3,510
Gross profit (loss) (447) (694) (1,334) (2,389)
Dermatology [Member]        
Segment Reporting Information [Line Items]        
Net revenue 846 1,682 2,929 4,688
Cost of revenue 903 1,505 2,576 3,590
Gross profit (loss) $ (57) $ 177 $ 353 $ 1,098